Risk of virus transmission through femoral head allografts: A Belgian appraisal

Journal of Clinical Orthopaedics and Trauma

Volumn 4, Issue 3, 2013, Pages 119-122

  Traore, Alidou ^a   Yombi, Jean Cyr ^a   Tribak, Karim ^a   Cornu, Olivier ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Allograft; Femoral head; Virus

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

AGED; ARTICLE; BELGIAN; BLOOD EXAMINATION; BONE ALLOGRAFT; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FEMORAL HEAD ALLOGRAFT; FEMUR HEAD; FEMUR IMPLANT; HEALTH CARE FACILITY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOASSAY; INCIDENCE; INFECTION CONTROL; INFECTION RISK; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SYPHILIS; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST; VENEREAL DISEASE REACTION TEST; VIRUS DIAGNOSIS; VIRUS TRANSMISSION;

EID: 84887023131     PISSN: 09765662     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcot.2013.07.001     Document Type: Article

References (33)

1. Transmission of HIV through bone transplantation: case report and public health recommendations. Morb Mortal Wkly Rep 1988, 37:597-599. Centers for disease control.
2. Delloye C. Tissue allografts and health risks. Acta Orthop Belg 1994, 60(S1):62-67.
3. Tomford W. Transmission of disease through tranplantation of musculoskeletal allografts. J Bone Joint Surg 1995, 77-A:1742-1754.
4. Eastlund T. Infectious disease transmission through tissue transplantation: reducing the risk through donor selection. J Transpl Coord 1991, 1:23-30.
5. Carlson E., Marx R., Buck B. The potential for HIV transmission through allogeneic bone. A review of risks and safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:17-23.
6. Nyberg M., Suni J., Haltia M. Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem. Am J Clin Pathol 1990, 94:422-425.
7. Conrad E.U., Gretch D.R., Obermeyer K.R., et al. Transmision of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg 1995, 77A:214-224.
8. Roth D., Fernandez J.A., Babischkin S., et al. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmision of disease. Ann Intern Med 1992, 117:470-475.
9. Dormont D. Creutzfeldt-Jakob disease and transplantation: facts and fables. Transplant Proc 1996, 28:2931-2933.
10. Report of WHO Consultation on Public Health Issues Related to Animal and Human Spongiform Encephalopathies November 12-14, 1991, World Health Organization, WHO, WHO/CDS/VPH/92.104.
11. Lemaire R., Masson J.B. Risk of transmision of blood-borne viral infection in orthopaedic and trauma surgery. J Bone Joint Surg 2000, 82B:313-323.
12. Delloye C. Current situation and future of tissue banking in orthopaedics. European Instructional Course Lectures 1993, vol. 1:161-172.
13. Sasse A., Van Kersschaever G., Stroobant A. Epidémiologie du sida et de l'infection à VIH en Belgique 2001, Situation au 31 décembre 2000, Institut Scientifique de la Santé Publique, IPH reports 2001-015.
14. Beutels M., Van Damme P., Aelvoet W., et al. Prevalence of hepatitis A, B and C in the flemish population. Eur J Epidemiol 1997, 13:275-280.
15. Van Damme P., Thyssen A., Van Loock F. Epidemiology of hepatitis C in Belgium: present and future. Acta Gastroenterol Belg 2002, 65:78-79.
16. Van Damme P., Tormans G., Beutels P., Van Doorslaer E. Hepatitis B prevention in Europe: a preliminary economic evaluation. Vaccine 1995, 13(suppl 1):S54-S57.
17. Lelie P., Zaaijer H., Cuypers H. Risk of virus transmission by tissue, blood and plasma products. Transplant Proc 1996, 28:2939.
18. Common Standards for Musculoskeletal Tissue Banking 1997, European Association of Musculo-Skeletal Transplantation (EAMST)/European Association of Tissue Banks (EATB), Vienna.
19. Directive 2004/23/EC of the European parliament and of the council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official J Eur Union 2004, L102:48-58. European Union.
20. Petersen L.R., Satten G.A., Dodd R., et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion 1994, 34:283-289.
21. Busch M.P., Lee L., Satten G., et al. Time course of detection of viral and serological markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995, 35:91-97.
22. Burtonboy G., Delloye C. Polymerase chain reaction in cadaveric blood and tissues. Transplant Proc 1996, 28:2927-2928.
23. Tobler L.H., Stramer S.L., Lee S.R., et al. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening. Transfusion 2003, 43:1452-1459.
24. Buck B., Resnick L., Shah S., Malinin T. Human immunodeficiency virus cultured from bone. Implications for transplantation. Clin Orthop 1990, 251:249-253.
25. Hirn M., Krusius T. Retesting of bone donors two months after donation guarantees sufficient safety of bone allografts. Acta Orthop Scand 1998, 69:566-569.
26. Horsburgh C.R., Ou C.Y., Jason J., et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989, 2:637-640.
27. Pereira B., Milfort E., Kirkman R., Levey A. Transmission of hepatitis C virus by organ transplantation. New Engl J Med 1991, 325:454-460.
28. Simonds R.J., Holmberg S.D., Hurwitz R.L., et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992, 326:726-732.
29. Tugwell B.D., Patel P.R., Williams I.T., et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005, 143:648-654.
30. Johnson C., Brown B., Lasky L. Rh immunization caused by osseous allograft. N Engl J Med 1985, 312:121-122.
31. Jensen T. Rhesus immunization after bone allografting. A case report. Acta Orthop Scand 1987, 58:584.
32. Sugihara S., van Ginkel A., Jiya T., van Royen B., van Diest P., Wuisman P. Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg 1999, 81B:336-341.
33. Palmer S., Gibbons C., Athanasou N. The pathology of bone allograft. J Bone Joint Surg 1999, 81B:333-335.